↓ Skip to main content
What is this page? Embed badge

Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma

Overview of attention for article published in Journal of Clinical Oncology, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent
34 patents
wikipedia
4 Wikipedia pages

Readers on

mendeley
73 Mendeley
So far, Altmetric has seen 4 citations on 4 Wikipedia pages.
This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.